Personalized Cell Therapy Market, By Cell Type (Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, and Others), by Therapeutic Area (Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, and Cancer), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • Published On : Nov 2019 |
  • Pages : 157 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Personalized Cell Therapy Market - Insights

Individualized treatment for various diseases such as cancer and autoimmune diseases by injecting living cells into a patient’s body is known as personalized cell therapy. It has various applications such as platelet transfusions, bone marrow transplantation, whole blood transfusions, packed red cell transfusions, and organ transplantation. It is used to treat various chronic conditions such as Parkinson’s disease and amyotrophic lateral sclerosis (neurological diseases), spinal cord injuries, diabetes, and cancer.

The global personalized cell therapy market was valued at US$ 8,046.30 million in 2018 and is expected to exhibit a CAGR of 23.5% during the forecast period (2019 – 2027).

Figure 1. Global Personalized Cell Therapy Market Size Analysis (US$ Mn) and Forecast and Absolute $ Opportunity

Personalized Cell Therapy  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increased economic burden due to neurological disorders is expected to fuel the global personalized cell therapy market growth

There are several studies conducted on stem cell or personalized cell therapy candidates to treat neurological disorder and spinal cord injury. For instance, in September 2016, MAPFRE Foundation, announced its first clinical trial results of personalized cell therapy in patients with complete and chronic spinal cord injury. The study was conducted to implant mesenchymal stem cells, which can create different types of tissue to treat spinal cord injury.

Increasing development of personalized cell therapy products along with high prevalence of lifestyle diseases is driving the global personalized cell therapy market growth

Rising prevalence of chronic diseases and increasing incidence of cancer is expected to fuel growth of the global personalized cell therapy market over the forecast period. For instance, according to the National Cancer Institute (NCI), in 2016, there were an estimated 15.5 million cancer cases that have been reported in the U.S. Moreover, according to NCI, in 2017, around 15,270 children and adolescents of age group of 0 to 19 were diagnosed with cancer in the U.S. Furthermore, according to the International Diabetes Federation (IDF), in 2017, over 425 million adults suffered from diabetes globally, and this is expected to reach 629 million by 2045.

Manufacturers are conducting large number clinical trials, in order to develop novel personalized cell therapies targeting chronic diseases such as cancer, diabetes, and other autoimmune diseases. For instance, in April 2019, Orgenesis Inc. a developer, and service provider of advanced cell therapies received Institutional Review Board (IRB) approval to collect liver biopsies from patients at Rambam Medical Center located in Haifa, Israel. The sample will be collected to confirm the safety and efficacy of liver cells for personalized cell replacement therapy in the patients with insulin-dependent diabetes resulting from total or partial pancreatectomy. Thus, increasing research studies is expected to drive the global personalized cell therapy market growth.

Global Personalized Cell Therapy Market- Regional Analysis

Regional segmentation of the global personalized cell therapy market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Better healthcare amenities along with high adoption of new technology for the treatment of chronic disease such as cancer, diabetes, renal dysfunction, and other autoimmune diseases in the developed economies is expected to boost overall sales of personalized cell therapy products, which in turn expected to drive the personalized cell therapy market growth over the forecast period. Moreover, number of research institutes in North America region are engaged in development of novel personalized cell therapy for various indications. For instance, in June 2019, University of Wisconsin’s (UW) Program for Advanced Cell Therapy (PACT) launched First-in-U.S. Cell Therapy Trial to treat a viral infection faced by kidney and/or pancreas transplant recipients.

Increasing approval for personalized cell therapy in Asia Pacific region is expected to boost the personalized cell therapy market growth. For instance, in February 2019, Ministry of Health, Labour and Welfare, Japan, approved production and sales of a CAR T-cell therapy, Kymriah therapy developed by Swiss pharmaceutical (Novartis), for treatment of the patients (young) with  leukemia. Moreover in February 2019, Ministry of Health, Labour and Welfare, Japan, approved human induced pluripotent stem cells therapy trial to treat spinal cord injury.  The trial was initiated by the researchers of Keio University in 2019.

Expansion of manufacturing facility for the increased production of personalized cell therapy in the U.K. is anticipated to witness the personalized cell therapy market growth in European region. For instance, in 2018, according to the Cell and Gene Therapy (CGT) Catapult report on U.K.’s cell and gene therapy industry, the U.K. has accounted for 60% increase in manufacturing space for personalized cell therapy developing, licensed by the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) and meeting Good Manufacturing Practice (GMP) standards

Figure 2. Global Personalized Cell Therapy Market Value Analysis, By Region - 2018

Personalized Cell Therapy  | Coherent Market Insights

Source: Coherent Market Insights (2019)

Market players operating in the global personalized cell therapy market include Cytori Therapeutics Inc., Bellicum Pharmaceuticals, Inc., Saneron CCEL Therapeutics, Inc., MolMed S.p.A., Vericel Corporation, Novartis AG, Gilead Sciences, Inc., Celgene Corporation, Bluebird Bio, Inc. and Aurora Biopharma Inc.

The patient-tailored therapies for the treatment of various diseases is known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients, who matches the specific disease physiopathology and/or patient characteristics. The personalized cell therapy is mainly developed for the treatment of high unmet need disease such as cancer, autoimmune disease, cardiovascular, neurologic, and inflammatory disease. Personalized cell therapy have application in platelet transfusions, packed red cell transfusions, bone marrow transplantation, and organ transplantation.

Personalized Cell Therapy Market Dynamics

Personalized cell therapy aids in accurate diagnosis of the disease and active monitoring of the treatment response, and disease progression. This allows for early detection of diseases at molecular level and allows physician to prepare treatment regime for the specific patient requirement. This helps the patient to recover at a significant pace and also helps avoid any major side effects, as individualized cell therapy is based on patient’s genomics.

Introduction of innovative personalized cell therapy and large number of cell therapies in pipeline by key players is expected to boost the market growth over the forecast period. For instance, in August 2017, the University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP) received the U.S. Food and Drug Administration (FDA) approval for its newly developed personalized cellular therapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

Key features of the study:

  • This report provides in-depth analysis of the global personalized cell therapy market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global personalized cell therapy market based on the following parameters – company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Cytori Therapeutics Inc., Bellicum Pharmaceuticals, Inc., Saneron CCEL Therapeutics, Inc., MolMed S.p.A., Vericel Corporation, Novartis AG, Gilead Sciences, Inc., Celgene Corporation, Bluebird Bio, Inc. and Aurora Biopharma Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, governmental initiatives, technological upgradation, market expansion, and marketing tactics
  • The global personalized cell therapy market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global personalized cell therapy market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Personalized Cell Therapy Market, By Cell Type:
    • Lymphocytes
    • Mesenchymal Stem Cell
    • Hematopoietic  Stem Cell
    • Others
  • Global Personalized Cell Therapy Market, By Therapeutic Area:
    • Cardiovascular Diseases
    • Neurological Disorders
    • Inflammatory Diseases
    • Diabetes
    • Cancer
  • Global Personalized Cell Therapy Market, By Region:
    • North America
      • North America Personalized Cell Therapy Market, By Cell Type:
        • Lymphocytes
        • Mesenchymal Stem Cell
        • Hematopoietic  Stem Cell
        • Others
      • North America Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • North America Personalized Cell Therapy Market, By Country:
        • U.S.
        • Canada
    • Europe
      • Europe Personalized Cell Therapy Market, By Cell Type:
        • Lymphocytes
        • Mesenchymal Stem Cell
        • Hematopoietic  Stem Cell
        • Others
      • Europe Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Europe Personalized Cell Therapy Market, By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Asia Pacific Personalized Cell Therapy Market, By Cell Type:
        • Lymphocytes
        • Mesenchymal Stem Cell
        • Hematopoietic  Stem Cell
        • Others
      • Asia Pacific Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Asia Pacific Personalized Cell Therapy Market, By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Latin America Personalized Cell Therapy Market, By Cell Type:
        • Lymphocytes
        • Mesenchymal Stem Cell
        • Hematopoietic  Stem Cell
        • Others
      • Latin America Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Latin America Personalized Cell Therapy Market, By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Middle East Personalized Cell Therapy Market, By Cell Type:
        • Lymphocytes
        • Mesenchymal Stem Cell
        • Hematopoietic  Stem Cell
        • Others
      • Middle East Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Middle East Personalized Cell Therapy Market, By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Africa Personalized Cell Therapy Market, By Cell Type:
        • Lymphocytes
        • Mesenchymal Stem Cell
        • Hematopoietic  Stem Cell
        • Others
      • Africa Personalized Cell Therapy Market, By Therapeutic Area:
        • Cardiovascular Diseases
        • Neurological Disorders
        • Inflammatory Diseases
        • Diabetes
        • Cancer
      • Africa Personalized Cell Therapy Market, By Country/Region:
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Cytori Therapeutics Inc. *
      • Company Overview
      • Product Portfolio
      • Strategies Presence
      • Key Developments
    • Bellicum Pharmaceuticals, Inc.
    • Saneron CCEL Therapeutics, Inc.
    • MolMed S.p.A.
    • Vericel Corporation
    • Novartis AG
    • Gilead Sciences, Inc.
    • Celgene Corporation
    • Bluebird Bio, Inc.
    • Aurora Biopharma Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Cell Type
      • Market Snippet, By Therapeutic Area
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers, Challenges, and Recommendations
      • Regulatory Scenario
      • Market Trends
      • Market Opportunities
      • Merger and Acquisitions
      • Key Developments
      • Approved Products and Industry Disruptive Force (CAR-T Cell Therapy)
  4. Global Personalized Cell Therapy Market, By Cell Type, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 - 2027
      • Segment Trends
    • Lymphocytes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Mesenchymal Stem Cell
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Hematopoietic Stem Cell
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  5. Global Personalized Cell Therapy Market, By Therapeutic Area, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 - 2027
      • Segment Trends
    • Cardiovascular Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Neurological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Inflammatory Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  6. Global Personalized Cell Therapy Market, By Region, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, By Geography, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Regional Trends
      • Regional Attractiveness Index
    • North America
      • Introduction
      • Market Share Analysis, By Cell Type, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Therapeutic Area, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Country, 2016 - 2027 (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Share Analysis, By Cell Type, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Therapeutic Area, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Country, 2016 - 2027 (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Share Analysis, By Cell Type, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Therapeutic Area, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Country, 2016 - 2027 (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Share Analysis, By Cell Type, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Therapeutic Area, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Country, 2016 - 2027 (US$ Million)
        • Brazil
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Share Analysis, By Cell Type, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Therapeutic Area2016 - 2027 (US$ Million)
      • Market Share Analysis, By Country, 2016 - 2027 (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Share Analysis, By Cell Type, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Therapeutic Area, 2016 - 2027 (US$ Million)
      • Market Share Analysis, By Country/Region, 2016 - 2027 (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Cytori Therapeutics Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Bellicum Pharmaceuticals, Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Saneron CCEL Therapeutics, Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • MolMed S.p.A.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Vericel Corporation
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Gilead Sciences, Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Celgene Corporation
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Bluebird Bio, Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
      • Aurora Biopharma Inc.
        • Company Highlights
        • Product Portfolio
        • Strategic Presence
        • Key Developments
        • Strategies
    • Analyst Views
  8. Section
    • Research Methodology
    • About us and Services

*Browse 23 market data tables and 19 figures on "Personalized Cell Therapy Market - Global forecast to 2027”.  

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.